Mon panier

PE-Labeled Rhesus macaque Mamu-A*01&B2M Tetramer Protein (Peptide free)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
MAM-RP2H4-25ug
$410.00
MAM-RP2H4-200ug (100ug X 2)
$2350.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    Mamu-A*01 & B2M

  • Source

    PE-Labeled Rhesus macaque Mamu-A*01&B2M Tetramer Protein (MAM-RP2H4) is expressed from human 293 cells (HEK293). It contains AA Gly 25 - Pro 307 (Mamu-A*01) & Ile 21 - Met 119 (B2M) (Accession # Q5TM76 (Mamu-A*01) & Q6V7J5 (B2M)).

    Predicted N-terminus: Gly 25 & Ile 21

    Request for sequence
  • Molecular Characterization

    PE-Labeled Rhesus macaque Mamu-A*01&B2M Tetramer Protein is assembled by biotinylated monomer and PE-labeled streptavidin.

    Biotinylated Rhesus macaque Mamu-A*01&B2M Monomer Protein is produced by co-expression of Mamu-A and B2M. This Protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

  • Conjugate

    PE

    Excitation Wavelength: 488 nm / 561 nm

    Emission Wavelength: 575 nm

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, 1% BSA, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Avis des utilisateurs